Institutional Ownership
Trisalus Life Sciences Inc
CUSIP 89680M119*W EXP 08/10/202TLSIWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Cerity Partners LLC | 827.6K | $993.1K |
| 2 | Citadel Advisors LLC | 65.2K | $78.2K |
| 3 | Aristeia Capital, L.L.C. | 28.6K | $35.8K |
| 4 | Fort Baker Capital Management LP | 26.4K | $31.6K |
| 5 | Toronto Dominion Bank | 5.2K | $6.5K |
| 6 | Vestcor Inc | 70.8K | $85 |
| 7 | Rockefeller Capital Management L.P. | 50 | $60 |